Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' MEYER UA' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 57 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Eiselt, R; Domanski, TL; Zibat, A; Mueller, R; Presecan-Siedel, E; Hustert, E; Zanger, UM; Brockmoller, J; Klenk, HP; Meyer, UA; Khan, KK; He, YA; Halpert, JR; Wojnowski, L
      Identification and functional characterization of eight CYP3A4 protein variants

      PHARMACOGENETICS
    2. Gellner, K; Eiselt, R; Hustert, E; Arnold, H; Koch, I; Haberl, M; Deglmann, CJ; Burk, O; Buntefuss, D; Escher, S; Bishop, C; Koebe, HG; Brinkmann, U; Klenk, HP; Kleine, K; Meyer, UA; Wojnowski, L
      Genomic organization of the human CYP3A locus: identification of a new, inducible CYP3A gene

      PHARMACOGENETICS
    3. Wong, JMY; Harper, PA; Meyer, UA; Bock, KW; Morike, K; Lagueux, J; Ayotte, P; Tyndale, RF; Sellers, EM; Manchester, DK; Okey, AB
      Ethnic variability in the allelic distribution of human aryl hydrocarbon receptor codon 554 and assessment of variant receptor function in vitro

      PHARMACOGENETICS
    4. Handschin, C; Podvinec, M; Stockli, J; Hoffmann, K; Meyer, UA
      Conservation of signaling pathways of xenobiotic-sensing orphan nuclear receptors, chicken xenobiotic receptor, constitutive androstane receptor, andpregnane X receptor, from birds to humans

      MOLECULAR ENDOCRINOLOGY
    5. Schuurmans, MM; Hoffmann, F; Lindberg, RL; Meyer, UA
      Zinc mesoporphyrin represses induced hepatic 5-aminolevulinic acid synthase and reduces heme oxygenase activity in a mouse model of acute hepatic porphyria

      HEPATOLOGY
    6. Handschin, C; Podvinec, M; Looser, R; Amherd, R; Meyer, UA
      Multiple enhancer units mediate drug induction of CYP2H1 by xenobiotic-sensing orphan nuclear receptor chicken xenobiotic receptor

      MOLECULAR PHARMACOLOGY
    7. Amherd, R; Hintermann, E; Walz, D; Affolter, M; Meyer, UA
      Purification, cloning, and characterization of a second arylalkylamine N-acetyltransferase from Drosophila melanogaster

      DNA AND CELL BIOLOGY
    8. Meyer, UA
      Pharmacogenetics and adverse drug reactions

      LANCET
    9. Handschin, C; Podvinec, M; Meyer, UA
      CXR, a chicken xenobiotic-sensing orphan nuclear receptor, is related to both mammalian pregnane X receptor (PXR) and constitutive androstane receptor (CAR)

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    10. Handschin, C; Meyer, UA
      A conserved nuclear receptor consensus sequence (DR-4) mediates transcriptional activation of the chicken CYP2H1 gene by phenobarbital in a hepatoma cell line

      JOURNAL OF BIOLOGICAL CHEMISTRY
    11. Ourlin, JC; Baader, M; Fraser, D; Halpert, JR; Meyer, UA
      Cloning and functional expression of a first inducible avian cytochrome P450 of the CYP3A subfamily (CYP3A37)

      ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
    12. Meyer, UA; Hoffmann, K
      Phenobarbital-mediated changes in gene expression in the liver

      DRUG METABOLISM REVIEWS
    13. Lindberg, RLP; Martini, R; Baumgartner, M; Erne, B; Borg, J; Zielasek, J; Ricker, K; Steck, A; Toyka, KV; Meyer, UA
      Motor neuropathy in porphobilinogen deaminase-deficient mice imitates the peripheral neuropathy of human acute porphyria

      JOURNAL OF CLINICAL INVESTIGATION
    14. Haller, L; Sossouhounto, R; Coulibaly, IM; Dosso, M; Kone, M; Adom, H; Meyer, UA; Betschart, B; Wenk, M; Haefeli, WE; Lobognon, LR; Porquet, M; Kabore, G; Sorenson, F; Reber-Liske, R; Sturchler, D
      Isoniazid plus sulphadoxine-pyrimethamine can reduce morbidity of HIV-positive patients treated for tuberculosis in Africa: A controlled clinical trial

      CHEMOTHERAPY
    15. BRODBECK D; AMHERD R; CALLAERTS P; HINTERMANN E; MEYER UA; AFFOLTER M
      MOLECULAR AND BIOCHEMICAL-CHARACTERIZATION OF THE AANAT1 (DAT) LOCUS IN DROSOPHILA-MELANOGASTER - DIFFERENTIAL EXPRESSION OF 2 GENE-PRODUCTS

      DNA and cell biology
    16. Rothen, JP; Haefeli, WE; Meyer, UA; Todesco, L; Wenk, M
      Acetaminophen is an inhibitor of hepatic N-acetyltransferase 2 in vitro and in vivo

      PHARMACOGENETICS
    17. Meyer, UA; Schuurmans, MM; Lindberg, RLP
      Acute porphyrias: Pathogenesis of neurological manifestations

      SEMINARS IN LIVER DISEASE
    18. MEYER UA
      POLYMORPHISMS AND EVOLUTION OF DRUG-METABOLIZING-ENZYMES

      Naunyn-Schmiedeberg's archives of pharmacology
    19. BOULEY L; DUTOIT P; MEYER UA; KUCERA P
      MOTOR PATTERNS IN AN ISOLATED ARTERIALLY-PERFUSED SMALL-INTESTINE OF THE MOUSE

      Gastroenterology
    20. SCOTT RJ; TAESCHNER W; HEINIMANN K; MULLER H; DOBBIE Z; MORGENTHALER S; HOFFMANN F; PETERLI B; MEYER UA
      ASSOCIATION OF EXTRACOLONIC MANIFESTATIONS OF FAMILIAL ADENOMATOUS POLYPOSIS WITH ACETYLATION PHENOTYPE IN A LARGE FAP KINDRED

      European journal of human genetics
    21. MAREZ D; LEGRAND M; SABBAGH N; LOGUIDICE JM; SPIRE C; LAFITTE JJ; MEYER UA; BROLY F
      POLYMORPHISM OF THE CYTOCHROME-P450 CYP2D6 GENE IN A EUROPEAN POPULATION - CHARACTERIZATION OF 48 MUTATIONS AND 53 ALLELES, THEIR FREQUENCIES AND EVOLUTION

      Pharmacogenetics
    22. ROCHAT B; AMEY M; GILLET M; MEYER UA; BAUMANN P
      IDENTIFICATION OF 3 CYTOCHROME-P450 ISOZYMES INVOLVED IN N-DEMETHYLATION OF CITALOPRAM ENANTIOMERS IN HUMAN LIVER-MICROSOMES

      Pharmacogenetics
    23. ROCHAT B; AMEY M; GILLET M; MEYER UA; BAUMANN P
      IDENTIFICATION OF 3 CYTOCHROME-P450 ISOZYMES INVOLVED IN N-DEMETHYLATION OF CITALOPRAM ENANTIOMERS IN HUMAN LIVER-MICROSOMES

      Pharmacogenetics
    24. MEYER UA; STOCKLI J; BAADER M; OURLIN JC; HOFFMANN K
      CYTOCHROME-P450 INDUCTION BY PHENOBARBITAL (PB) IN CHICK-EMBRYO HEPATOCYTES AND HEPATOMA-CELLS

      The FASEB journal
    25. MEYER UA; ZANGER UM
      MOLECULAR MECHANISMS OF GENETIC POLYMORPHISMS OF DRUG-METABOLISM

      Annual review of pharmacology and toxicology
    26. MEYER UA; FRUH FW; JOVER R; HOFFMANN K; OURLIN JC
      MECHANISMS OF INDUCTION OF DRUG-METABOLIZING-ENZYMES - POTENTIALS ANDLIMITATIONS OF IN-VITRO MODELS

      Naunyn-Schmiedeberg's archives of pharmacology
    27. FRUEH FW; ZANGER UM; MEYER UA
      EXTENT AND CHARACTER OF PHENOBARBITAL-MEDIATED CHANGES IN GENE-EXPRESSION IN THE LIVER

      Molecular pharmacology
    28. LINDBERG RLP; PORCHER C; GRANDCHAMP B; LEDERMANN B; BURKI K; BRANDNER S; AGUZZI A; MEYER UA
      PORPHOBILINOGEN DEAMINASE DEFICIENCY IN MICE CAUSES A NEUROPATHY RESEMBLING THAT OF HUMAN HEPATIC PORPHYRIA

      Nature genetics
    29. AGUNDEZ JAG; OLIVERA M; LADERO JM; RODRIGUEZLESCURE A; LEDESMA MC; DIAZRUBIO M; MEYER UA; BENITEZ J
      INCREASED RISK FOR HEPATOCELLULAR-CARCINOMA IN NAT2-SLOW ACETYLATORS AND CYP2D6-RAPID METABOLIZERS

      Pharmacogenetics
    30. DALY AK; BROCKMOLLER J; BROLY F; EICHELBAUM M; EVANS WE; GONZALEZ FJ; HUANG JD; IDLE JR; INGELMANSUNDBERG M; ISHIZAKI T; JACQZAIGRAIN E; MEYER UA; NEBERT DW; STEEN VM; WOLF CR; ZANGER UM
      NOMENCLATURE FOR HUMAN CYP2D6 ALLELES

      Pharmacogenetics
    31. FUHR U; ROST KL; ENGELHARDT R; SACHS M; LIERMANN D; BELLOC C; BEAUNE P; JANEZIC S; GRANT D; MEYER UA; STAIB AH
      EVALUATION OF CAFFEINE AS A TEST DRUG FOR CYPIA2, NAT2 AND CYP2E1 PHENOTYPING IN MAN BY IN-VIVO VERSUS IN-VITRO CORRELATIONS

      Pharmacogenetics
    32. MEYER UA
      METABOLIC INTERACTIONS OF THE PROTON-PUMP INHIBITORS LANSOPRAZOLE, OMEPRAZOLE AND PANTOPRAZOLE WITH OTHER DRUGS

      European journal of gastroenterology & hepatology
    33. HA HR; CANDINAS R; STIEGER B; MEYER UA; FOLLATH F
      INTERACTION BETWEEN AMIODARONE AND LIDOCAINE

      Journal of cardiovascular pharmacology
    34. MEYER UA
      OVERVIEW OF ENZYMES OF DRUG-METABOLISM

      Journal of pharmacokinetics and biopharmaceutics
    35. MEYER UA
      INTERACTION OF PROTON PUMP INHIBITORS WITH CYTOCHROMES P450 - CONSEQUENCES FOR DRUG-INTERACTIONS

      The Yale journal of biology & medicine
    36. BONT A; STECK AJ; MEYER UA
      THE ACUTE HEPATIC PORPHYRIAS AND THEIR NEUROLOGIC SYNDROMES

      Schweizerische medizinische Wochenschrift
    37. HINTERMANN E; GRIEDER NC; AMHERD R; BRODBECK D; MEYER UA
      CLONING OF AN ARYLALKYLAMINE N-ACETYLTRANSFERASE (AANAT1) FROM DROSOPHILA-MELANOGASTER EXPRESSED IN THE NERVOUS-SYSTEM AND THE GUT

      Proceedings of the National Academy of Sciences of the United Statesof America
    38. JOVER R; LINDBERG RLP; MEYER UA
      ROLE OF HEME IN CYTOCHROME-P450 TRANSCRIPTION AND FUNCTION IN MICE TREATED WITH LEAD ACETATE

      Molecular pharmacology
    39. KAUFMANN GR; WENK M; TAESCHNER W; PETERLI B; GYR K; MEYER UA; HAEFELI WE
      N-ACETYLTRANSFERASE-2 POLYMORPHISM IN PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS

      Clinical pharmacology and therapeutics
    40. JOVER R; HOFFMANN K; MEYER UA
      INDUCTION OF 5-AMINOLEVULINATE SYNTHASE BY DRUGS IS INDEPENDENT OF INCREASED APOCYTOCHROME P450 SYNTHESIS

      Biochemical and biophysical research communications
    41. MEYER UA; AMREIN R; BALANT LP; BERTILSSON L; EICHELBAUM M; GUENTERT TW; HENAUER S; JACKSON P; LAUX G; MIKKELSEN H; PECK C; POLLOCK BG; PRIEST R; SJOQVIST F; DELINISTULA A
      ANTIDEPRESSANTS AND DRUG-METABOLIZING-ENZYMES - EXPERT GROUP-REPORT

      Acta psychiatrica Scandinavica
    42. BROLY F; MAREZ D; SABBAGH N; LEGRAND M; MILLECAMPS S; LOGUIDICE JM; BOONE P; MEYER UA
      AN EFFICIENT STRATEGY FOR DETECTION OF KNOWN AND NEW MUTATIONS OF THECYP2D6 GENE USING SINGLE-STRAND CONFORMATION POLYMORPHISM ANALYSIS

      Pharmacogenetics
    43. BROSEN K; DEMORAIS SMF; MEYER UA; GOLDSTEIN JA
      A MULTIFAMILY STUDY ON THE RELATIONSHIP BETWEEN CYP2C19 GENOTYPE AND S-MEPHENYTOIN OXIDATION PHENOTYPE

      Pharmacogenetics
    44. VATSIS KP; WEBER WW; BELL DA; DUPRET JM; EVANS DAP; GRANT DM; HEIN DW; LIN HJ; MEYER UA; RELLING MV; SIM E; SUZUKI T; YAMAZOE Y
      NOMENCLATURE FOR N-ACETYLTRANSFERASES

      Pharmacogenetics
    45. BROLY F; MAREZ D; LOGUIDICE JM; SABBAGH N; LEGRAND M; BOONE P; MEYER UA
      A NONSENSE MUTATION IN THE CYTOCHROME-P450 CYP2D6 GENE IDENTIFIED IN A CAUCASIAN WITH AN ENZYME DEFICIENCY

      Human genetics
    46. HINTERMANN E; JENO P; MEYER UA
      ISOLATION AND CHARACTERIZATION OF AN ARYLALKYLAMINE N-ACETYLTRANSFERASE FROM DROSOPHILA-MELANOGASTER

      FEBS letters
    47. KEMPF AC; ZANGER UM; MEYER UA
      TRUNCATED HUMAN P450 2D6 - EXPRESSION IN ESCHERICHIA-COLI, NI2-CHELATE AFFINITY PURIFICATION, AND CHARACTERIZATION OF SOLUBILITY AND AGGREGATION()

      Archives of biochemistry and biophysics
    48. TAESCHNER W; MEYER UA
      PREDICTION OF GENETIC-VARIATION OF DRUG-METABOLISM

      European journal of pharmaceutical sciences
    49. MEYER UA
      POLYMORPHISM OF HUMAN ACETYLTRANSFERASES

      Environmental health perspectives
    50. MEYER UA
      PHARMACOGENETICS - THE SLOW, THE RAPID, AND THE ULTRARAPID

      Proceedings of the National Academy of Sciences of the United Statesof America
    51. DEMORAIS SMF; WILKINSON GR; BLAISDELL J; MEYER UA; NAKAMURA K; GOLDSTEIN JA
      IDENTIFICATION OF A NEW GENETIC-DEFECT RESPONSIBLE FOR THE POLYMORPHISM OF (S)-MEPHENYTOIN METABOLISM IN JAPANESE

      Molecular pharmacology
    52. MEYER UA
      THE MOLECULAR-BASIS OF GENETIC POLYMORPHISMS OF DRUG-METABOLISM

      Journal of Pharmacy and Pharmacology
    53. PROBST MR; BEER M; BEER D; JENO P; MEYER UA; GASSER R
      HUMAN LIVER ARYLACETAMIDE DEACETYLASE - MOLECULAR-CLONING OF A NOVEL ESTERASE INVOLVED IN THE METABOLIC-ACTIVATION OF ARYLAMINE CARCINOGENSWITH HIGH SEQUENCE SIMILARITY TO HORMONE-SENSITIVE LIPASE

      The Journal of biological chemistry
    54. DEMORAIS SMF; WILKINSON GR; BLAISDELL J; NAKAMURA K; MEYER UA; GOLDSTEIN JA
      THE MAJOR GENETIC-DEFECT RESPONSIBLE FOR THE POLYMORPHISM OF S-MEPHENYTOIN METABOLISM IN HUMANS

      The Journal of biological chemistry
    55. ROTHMAN N; HAYES RB; BI WF; CAPORASO N; BROLY F; WOOSLEY RL; YIN SN; FENG PW; YOU XJ; MEYER UA
      CORRELATION BETWEEN N-ACETYLTRANSFERASE ACTIVITY AND NAT2 GENOTYPE INCHINESE MALES

      Pharmacogenetics
    56. BROLY F; MEYER UA
      DEBRISOQUINE OXIDATION POLYMORPHISM - PHENOTYPIC CONSEQUENCES OF A 3-BASE-PAIR DELETION IN EXON 5 OF THE CYP2D6 GENE

      Pharmacogenetics
    57. ANDERSSON T; MINERS JO; VERONESE ME; TASSANEEYAKUL W; TASSANEEYAKUL W; MEYER UA; BIRKETT DJ
      IDENTIFICATION OF HUMAN LIVER CYTOCHROME-P450 ISOFORMS MEDIATING OMEPRAZOLE METABOLISM

      British journal of clinical pharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 06/06/20 alle ore 14:19:30